Business Daily from THE HINDU group of publications
Tuesday, Nov 18, 2008
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Venture Capital
McNally Capital plans investment in biotech, healthcare sectors

US-based PE firm has $1b funds on call.


At present, McNally has invested $25 million in Indian companies which include two service providers based out of Hyderabad.


G. Naga Sridhar

Hyderabad, Nov. 17 Chicago-based private equity player McNally Capital is planning to invest in the Indian biotech, healthcare and food-processing industries in view of the sound fundamentals, according to its Managing Partner, Mr John P. Rompon.

Talking to Business Line on the sidelines of a CEOs club meeting of the Federation of Andhra Pradesh Chambers of Commerce and Industry (FAPCCI) here on Saturday, Mr Rompon said there has been greater interest on investing in India due to slowdown in the US economy.

The investment of 100 families in the US whose wealth is in excess of $100 million is routed by McNally. “Though our fund size is $75 million in general, we can access greater funds if there is an attractive investment opportunity,” he said.

The member-families of McNally usually invest 90 per cent of their wealth in the publicly traded companies leaving the rest for private equity investment abroad. “Due to the slowdown, we are looking for safer and better returns on equity investment,” he added.

At present, McNally has invested $25 million in Indian companies which include two service providers based out of Hyderabad. “We have also invested in Indian companies engaged in food and healthcare business here and want to ramp it up further,” Mr Rompon said while declining to name any companies.

GOOD OPPORTUNITY

On the likely impact of US slowdown on the bilateral investment pattern, he said: “This is indeed a good opportunity for Indian investors to buy equity in the small businesses in the US due to drastic dip in their valuations.”

The US investor perception about investing in India remained highly positive and there should be no bottlenecks in investment. “The drivers for US investment in India are transparency in contracts, rule of law, and high liquidity in the stock markets. It is easier in India to take a company public and exit safely,” he pointed out.

McNally would stay invested for 5-7 years in a company, he added.

“But the problem with Indian companies is that they are active in soliciting investment from outside but they don’t spend it on the expansion immediately. This may impact return on equity,” he observed.

More Stories on : Venture Capital | Financial Services

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
Bharati Shipyard yet to receive order for FCCB conversion


CANDU’s vendor eyes Indian nuclear market
IPAB hears Novartis’ Glivec case
Jubilant acquires Canadian co
Super luxury homes project
Odyssey puts on hold expansion in new cities
Oil sector officers’ strike deferred
JSW Steel, UK’s Severfield to float jt venture
McNally Capital plans investment in biotech, healthcare sectors
Dunlop’s Sahagunj unit headed for temporary closure
Cairn urges Ministry to decide fast on nominee refineries
NACIL invites bids for sale, leaseback of aircraft
Tata Chem to build up liquidity, conserve cash
SAIL sets up five task forces




eWorld



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line